3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of biological products, recently awarded the best Final Project Degree (FPD) of Pharmacy.
The award forms part of an agreement between 3P and the Faculty of Pharmacy at the University of Navarra promoting digital transformation and professional training within the pharmaceutical industry. At the same time, encouraging research in technologies, and the production of new medicines, particularly in biotechnologies.
The first winner of the 3P award is Ángela Covo, a Pharmacy degree student, for her experimental work on: “Overcoming T cell dysfunction in the acidic tumor microenvironment.” Ángela successfully achieved a grade of 9.32 and was awarded a prize of €300 and a diploma.
According to the CEO of 3P Biopharmaceuticals, Dámaso Molero, “It is an honor to be able to present the first 3P Biopharmaceuticals Award for the best Final Degree Project. All the graduating students have obtained very high grades and it tells us that we are training future professionals with a technical-scientific profile of the highest level who will add a lot of value to Navarra and the Spanish biopharmaceutical sector.”
The agreement with 3P and the Pharmacy Faculty concentrates on new medicine and advanced therapies in R&D, including the development of biological drugs, cell and gene therapy, manufacturing and analytical technology, and dispensing technology. With the intention of manufacturing drugs that are safer and aimed at diseases that, until now, have no cure or with treatments without serious side effects.
In addition to the 3P Final Degree Project award, the collaboration between the two bodies delivers events, courses, seminars, and scientific meetings.
View the full press release here
Un equipo de investigadores de la Universidad Juli...
A new technique allows the design of solid materia...
En nuestro post hablamos sobre este interesante tipo de célula del...
They have led the largest brain imaging study of children aged 9 to 11...
Biotechnology portal in Spain
Subscribe to our newsletter and stay up to date with the latest news and deals!